Dr. David Ai is Director of Knowledge Transfer at the City University of Hong Kong.  Prior to 2014, he worked for Stanford University's Office of Technology Licensing for six years, managing inventions while spearheading Stanford's effort to market its technologies to China.

Previously, Dr. Ai was Chief Advisor at Hitachi Corporate VC until 2006, where he scored two successful acquisitions and one IPO among the four VC investments he led. 

Earlier, Dr. Ai founded an award-winning e-healthcare in Beijing.  As interim CEO he secured $6M VC investment in the first foreign-owned cancer center in Shanghai.  He was VP/GM at Varian Medical (NYSE: VAR), VP of Marketing at Cirque (acquired by ALPS Japan), and Project Manager at Hewlett-Packard.

Dr. Ai received a BS in psychology (National Taiwan University), an MS in computer science (Indiana University), an MBA (Stanford), and most recently a J.D. (Santa Clara University).  He is a patent attorney (California).

Dr. Au is the Co-Founder of OneBusinessAsia, a collaborative platform of capital and innovations among entrepreneurs, investors and professionals in Asia. Prior to the founding of the OBA Group, he served as software engineer, database specialist, product manager in multinational companies including Bell Canada, IBM, Bank of America, and as executive director in Goldman Sachs Asia and sessional law lecturer in University of British Columbia, for a total of 20+ years. He is also the principal of MKA Law Office, a Hong Kong law firm with practice areas covering corporate, commercial, securities, I.T./I.P., and cross-border transactions. Dr. Au is also a member of Hong Kong Computer Society, Hong Kong Securities and Investment Institute, Hong Kong Law Society, Hong Kong Institute of Arbitrators, and Hong Kong Institute of Patent Attorneys.

Dirk Brown is the Faculty Director of the University of South Carolina's McNair Institute for Entrepreneurism and Free Enterprise and a faculty member in the Management Department at the Darla Moore School of Business. Dr. Brown is a seasoned executive with a strong track record of developing, marketing and licensing disruptive, proprietary technologies. He is the founding CEO of Pandoodle Corporation, a digital media technology company with offices in California, New York and South Carolina. Previously, he was CEO of Neoconix, a venture capital-funded electronics technology company serving Fortune 100 customers with worldwide sales and manufacturing.

Earlier in his career, Dr. Brown was executive vice president of operations and marketing at High Connection Density, with P&L responsibility for all of the company's product lines, and before that a member of technical staff at Advanced Micro Devices. He holds over 25 patents, has written over 30 technical papers and journal articles, and is an active member in a number of professional societies.

Dr. Brown holds an MBA from San Jose State, a Ph.D. (Materials Science) and M.Eng. (Applied Physics) from Cornell University and a B.Sc. (Eng.) in Applied Physics/Electrical Engineering from Queen's University in Canada.

Dr. Albert Wai-Kit Chan is the Managing Partner of the Law Offices of Albert Wai-Kit Chan, PLLC. He is a former research scientist who forged his legal career by combining his training as a molecular biologist with the emerging legal needs of the biotechnology industry in the late 1980s. Dr. Chan handles all areas of intellectual property law (including technology transfer, patents, trademarks, copyrights, business transactions, and trade secrets), and his specialty is biotechnology patents.  He is well-versed in all aspects of prosecution and litigation and is experienced in licensing, technology transfer and the evaluation of intellectual property portfolios. Dr. Chan works extensively with both U.S. and international companies.  He has helped scores of scientists and inventors obtain the intellectual property protection they need to be competitive in their fields.  His clients range from individual inventors to up-and-coming companies to well-established prestigious research institutes.

Dr. Chan has been frequently involved in transactional work in China, which includes facilitating joint ventures and contracts between East and West companies and building up clients' intellectual property portfolios.  For those clients looking to expand their business in China, he has not only provided patent procurement services but also, equally important, patent enforcement. He has performed analysis and evaluation of clients' intellectual property to determine the scope and securement of the protection of their intellectual property.

From 1996 through 2013, Dr. Chan taught as an adjunct professor of law at The City University of New York School of Law. His classes included intellectual property law, patent law, technology transfer, Internet and the law, food and drug law, and international business law.  He is currently adjunct associate professor in the School of Life Sciences at The Chinese University of Hong Kong and has adjunct professorship in the Department of Health Technology and Informatics at The Hong Kong Polytechnic University. Dr. Chan is active in a number of legal organizations including, among others, United States-China Intellectual Property Institute, Inc. (a New York Not-For-Profit Corporation) where he is founder and director.

Dr. Chan received his J.D. degree from Columbia University School of Law in New York. He was awarded his Ph.D. in virology at Baylor College of Medicine in Houston, Texas, and he completed his postdoctoral training at Cold Spring Harbor Laboratory in New York as an American Cancer Society postdoctoral fellow.  Dr. Chan is a graduate of The Chinese University of Hong Kong, and he was born and raised in Hong Kong.

Dr. Keith Chan is a pharmaceutical scientist, a regulator, a professor and an entrepreneur. He obtained his Ph.D. degree in Pharmaceutics from University of Minnesota in 1980.  He is currently Senior Advisor of Cornerstone IP Foundation, Professor at the Graduate Institute of Intellectual Property and Technology Management, College of Commerce, National Chengchi University at Taiwan. He is also a Senior Research Fellow at Institute of International Intellectual Property at Beijing University Law School.  He also serves as Director of International Affairs, GloboAsia LLC, Rockville, MD, USA and as advisors for several research institutes and regulatory agencies in Asia, as well as consultants for several pharmaceutical firms in Asia and in the US.

His co-foundered GloboMax LLC, a drug development organization, in Hanover, Maryland in 1997 and served as consultant for numerous multi-national pharmaceutical and biotech firms in the US, Europe and Asia.  GloboMax was acquired by ICON, plc in 2003 and Dr. Chan exited from the operation.  He also worked for the US FDA as Division Director at the Office of Generic Drugs.  He served as adjunct Professor at the School of Pharmacy, University of Maryland at Baltimore for many years and also served as Adjunct Professor and National Board of Advisor, College of Pharmacy, University of Minnesota since 1984. He also taught in Asia including National Defense Medical Center, National Yang Ming University in Taiwan and Shang Yang Pharmaceutical University in China. He worked for Ciba-Geigy Corporation in Ardsley, New York for 15 years and held various senior and management positions.  He published more than 150 abstracts and research articles in peer-reviewed journals and over 200 professional presentations.  He was elected as fellow of the American Association of Pharmaceutical Scientists (AAPS) in 1995 for his scientific accomplishments on drug absorption in humans.

Even though his major career works are in the States, he also assists Asian pharmaceutical and biotech companies over the last 14 years.  He had organized numerous workshops and conferences in China, Taiwan, Hong Kong, Singapore, and Korea.  He served and still serving as a scientific advisor for many regulatory agencies in Asia.   He lectured frequently in the Asia in the hope to upgrading their pharmaceutical industry.  Over the last several years, he had successfully in assisting many Asian companies in their technology transfers and licensing. His most recent accomplishment was to lead a Taiwan company to complete a new drug development program starting from IND up to NDA. The drug is now marketed and launched in Japan, United States, Taiwan and Europe for the treatment of chronic kidney diseases and end stage renal disease involving dialysis.

Ms. Chau graduated from the University of Hong Kong and obtained her Bachelor of Laws degree and Postgraduate Certificate in Laws from the University of Hong Kong.  In addition, Ms. Chau has also obtained her Master of Laws Degree from the London School of Economics and Political Science and Master of Laws Degree from the Renmin University of China.

Ms. Chau is conversant in English, Cantonese and Mandarin, and she is capable of drafting English and Chinese documents.  Since joining Origin Business Consultancy Company Limited, Ms. Chau is mainly involved in the management of trade marks applications and corporate compliance matters.

Before joining Origin Business Consultancy Company Limited, Ms. Chau has worked in the Registration Team of the Intellectual Property Department.  During that time, Ms. Chau has assisted in the drafting of consultation documents relating to the Consultation on the Proposed Application of the Protocol Relating to the Madrid Agreement Concerning the International Registration of Marks (Madrid Protocol) to Hong Kong by the Government, she has also advised on registrability issues relating to trade marks, and has handled ex-parte registrability hearings and inter partes interlocutory hearings (for example, time extension applications).

Prof. Dongmin Chen is a Chair Professor in Peking University Big Data Institute. He heads the Planning Committee for School of Innovation and Entrepreneurship at PKU. From 2012-1026 He served as the Director of Office of Science and Technology Development at PKU, and has overseen the university innovation ecosystem development, including technology licensing, spin-offs, several incubators and investment funds, and entrepreneurship education programs. He was a former Sr. Rowland Fellow at Harvard University for 15 years and a serial entrepreneur and co-founder of two Silicon Valley companies. Prof. Chen is the International Adviser of WIPO Global Innovation Index and the Honorary Advisor and former Chairman & President of Chinese American Semiconductor Professional Association. Prof. Chen is an Associate Editor of Applied Physics letter. His research expertise includes nanotechnologies, RRAM, MEMS-CMOS integration; wearable sensor, Tele-medicine and big-data in health-informatics. He co-authored more than 70 scientific publications and 150 US and international patents.

Jyh-Kwang (Matt) Chen is an intellectual property expert at Tencent.  His practice mainly focuses on the company's overseas patent-related matters, including patent litigation, licensing, transaction and negotiation.  Prior to joining Tencent, Mr. Chen was a senior legal counsel at Taiwan Semiconductor Manufacturing Company (TSMC) where he had sucessfully defended TSMC and/or its customers in Section 337 investigations before USITC, patent litigations in U.S. district courts, inter parte reviews (IPRs) before PTAB, and also in licensing negotiations with several major patent assertion entities.  Mr. Chen had also worked in two international law firms where he counseled high tech. companies in Taiwan and China in U.S. patent prosecution, litigation, licensing negotiation and portfolio management.  Mr. Chen received B.S.E.E. and master of law degrees from National Taiwan Univ. and LL.M. degree from Stanford Law School.

Chinese licensed attorney, Registered Foreign Lawyer of Hong Kong
Legal consultation expert for Guangzhou Municipal Government
Deputy Director of Continual Education Committee of Guangdong Province Lawyers Association
Former Director of the IP Committee of Guangdong Province Lawyers Association
Adjunct Professor, Lawyer School of South China Normal University

European Patent Attorney, Swedish Patent Attorney- who is on "garden leave" from the IP law firm Brann AB and starting at a new IP law firm (which, for contractual reasons, he cannot name yet) in September 2017.

Barry Franks started working in IP in 1983 following his graduation from the University of Bath with a degree in Mechanical Engineering with French. Barry has pursued an exceptionally broad career – both geographically and operatively, starting with ten years as an examiner at the EPO in The Hague. He moved to Sweden and spent two years as an entrepreneur before returning to the world of IP as a patent attorney in Stockholm and Uppsala. After five years' experience of drafting, prosecuting and using IP for small, medium and large companies in fields as diverse as diapers (what he calls the "biohazard industry") and fuel rod extractors for nuclear power plants (a different type of potential hazard), he was headhunted by a global healthcare company Amersham Pharmacia Biotech which subsequently became part of GE Healthcare. He spent almost seven interesting and educative years there as in-house counsel, first in Sweden and subsequently in the UK, responsible for its European hardware IP portfolio. The commercial outlook and pragmatic decision-making skills acquired in industry have been put to first-rate use since he returned to Sweden and re-joined the IP Law firm Brann AB as manager of the Uppsala office. In addition to advising his clients on freedom-to-operate, due diligence, IP strategy and IP management, he started to specialise in oral proceedings before the EPO. As recognition grew of his enthusiasm for (and skill in winning) difficult oral proceedings he relinquished the role of manager to again concentrate full-time on IP matters. As well as a good working knowledge of French, Dutch and German, he is fluent in Swedish - which is much appreciated by his local clients when it comes to advising them on the finer points of IP law or discussing strategies.

Barry lectured for many years for the Swedish Patent Office and the Swedish IP Academy and in recent years has been invited to lecture on oppositions and oral proceedings in China, India and Mexico where his practical advice mixed with relevant anecdotes has been warmly received.  He has also contributed chapters to a number of well-known IP reference books.

Barry regularly appears in the Intellectual Asset Management magazine "Patent 1000" as a peer-nominated "highly recommended individual" for patent prosecution and is also honoured as a peer-nominated "IP Star" by Managing Intellectual Property magazine.

Danny Friedmann is a reseacher / lecturer of intellectual property law and the Castetter Visiting Scholar at the California Western School of Law in San Diego. Previously he was Research Associate, Lecturer and Tutor at the Chinese University of Hong Kong. Friedmann received his PhD in Laws from the Chinese University of Hong Kong in 2013, his LLM from the University of Amsterdam, the Netherlands in 2006. Friedmann received the Post Graduate Research Output Award 2013 from the Chinese University of Hong Kong. Friedmann has been involved with WILMap of the Stanford Center for Internet and Society since 2014. His monograph, called 'Trademarks and Social Media, Towards Algorithmic Justice' was published by Edward Elgar Publishing in 2015. His peer-reviewed articles are published by Journal of Intellectual Property Law and Practice (Oxford University Press), European Intellectual Property Review, Benelux Trade Marks and Design Rights (BMM) Bulletin and GRUR Int. His book chapter on Google and China was quoted by the Advocate General of the Court of Justice of the European Union in Google Spain C-131/12 in 2013. His blog called IP Dragon, http://ipdragon.org, which he founded in 2005, is widely read. In 2015 Friedmann became member of the Editorial Board of the Journal of Intellectual Property Law and Practice. Since 2016, he is Principal Commentator at the University of Macau for the external examination of oral defenses of theses. Email: ipdragon@gmail.com

Founder of AUGUZ
Authorised Person, HK
ARBHK (Registered Architect), HK
ARBUK (Registered Architect), UK
RIBA HK Chapter Committee Member, HK
RIBA (Chartered Member), UK
HKIA (Member), HK
MArch Royal College of Art, UK
BArch (1st Hon) University of Hong Kong

Professor Christopher Gane was appointed Dean of the Faculty of Law in September 2011. Prior to coming to the Chinese University of Hong Kong he held the Chair of Scots Law at the University of Aberdeen where he was Dean of the Faculty of Law from 1995 to 2000. In 2004 he was appointed University Vice-Principal (Pro Vice-Chancellor) and over the next seven years was responsible for a number of strategic portfolios, including Library and Information Services, Culture and Communities and Equality and Diversity. In 2008 he was appointed Head of the College of Arts and Social Sciences (which comprises the Schools of Business; Divinity, History and Philosophy; Education; Language and Literature; Law; Social Sciences).

Prior to his appointment at Aberdeen he held academic appointments at the Universities of Reading, Edinburgh, Lancaster and Sussex. Between 1986 and 1989 he was Head of the Department of Law at the University of Lancaster. From 1991-1994 he was Director of the Centre for Legal Studies at the University of Sussex.

His research and teaching interests include domestic Criminal Law and Procedure, International Criminal Law and Human Rights. He is the author, co-author or editor of twelve books / editions and more than fifty scholarly articles and papers.

He has acted as consultant to the Scottish Executive in respect of their Human Rights obligations under the Scotland Act 1998 and the Human Rights Act 1998, as advisor to the Scottish Parliament on a number of criminal law, criminal justice and criminal procedure Bills and as advisor to the Scottish Government on European Union criminal law and procedure. He was a member of the Committee appointed by the Secretary of State for Scotland to review the Law on disposals of serious violent and serious sex offenders (the McLean Committee) and a member of the Sentencing Commission for Scotland throughout its term of appointment. He was the co-founder of the group which produced the Draft Criminal Code for Scotland, published by the Scottish Law Commission. In 1997 he was appointed an Honorary Sheriff of Grampian Highland and Islands at Aberdeen.

Douglas currently is CEO of Ideation Inc that has built a software tool that allows any organization or individual to build their own white labelled innovation ecosystem. Prior to this he restructured Circle Trust an $8.5 billion bank and stayed on as Chairman and CEO through three successive owners. He was a Managing Director at KPMG responsible for Financial Services, e-Commerce and CyberSecurity and led several large industry infrastructure projects including NetAid (1700 servers in five continents), Furs.com, NICC (Newspaper Industry Clearing Center) and OASIS that deregulated the wholesale electrical industry and for which he won a Gartner award. He has written two books for Wiley – the first on secure Internet architectures that was translated to three languages and one on Ideation: The Birth & Death of Ideas that was well reviewed by Carl Icahn and Lee Iacocca. Inventor on five patents (one with 260 citations). He is interested in innovation management, Big Data analytics, cybersecurity, funds management, blockchain technology and cryptocurrencies.

Xiaoman is a registered Chinese Patent Attorney and approved. She has more than 16 years experience working in Intellectual property area in China starting her IP career in Jeekai & Partners. She used to work for multinational companies as IP head in China and she has extensive experience with IP considerations and problems and the tactics for solving such problems in China. She  joined  Shangcheng  as  partner  5 years  ago  and  provides  all  kind  of IP services to domestic and foreign clients.

Xiaoman received her Master in Medicine degree from a well-known Chinese Medical Institute in Beijing.  Xiaoman specializes in patent drafting, prosecution, FTO  analysis,  patent  validity  analysis,  patent  infringement  opinion,  patent portfolio management, IP strategy making, IP due diligence in M&A, IP infringement litigation, patent validity & patent re-examination procedure, trade secret protection.

She is a member of ACPAA, AIPPI, AIPLA and INTA.

Dr. Xin Guo, MBA of Xi'an Jiaotong University. Guo qualifies as board secretary of listed company in Shenzhen Stock Exchange and has been board director or supervisor of several technology companies. From July of 2010 till now, he dedicates to industrialize the academic research in Xi’an Institute of Optics and Precision Mechanics of CAS. He is currently an assistant of chairman and head of strategic development department of Xike Holdings, a capital management company wholly owned by Xi’an Institute of Optics and Precision Mechanics of CAS, and investment director of CASSTAR, responsible for enterprise management, fund raising, investment of technology industrialization, and the liaison to external governmental administration, such as National Development and Reform Commission, Ministry of Finance, Ministry of Science and Technology, Chinese Academy of Science, and various fund of funds. He had been previously board secretary of Femtosecond Optics.

Tianxiang He (China P. R. 1984) is Assistant Professor at the School of Law, City University of Hong Kong. Dr. He holds an LL.B. degree (Huaqiao University, China, 2007) and a Master degree in International Law (Jinan University, China, 2009). Dr. He received his degree of Ph.D. in IP law at Maastricht University (the Netherlands, 2016), where he was Researcher at the Department of International and European Law, and Ph.D. Fellow at Institute for Globalization and International Regulation (IGIR), and another Ph.D. degree in Criminal Law at Renmin University of China (2017).

From August 2012 to July 2013, Dr. He worked in the Research Center of for the Legal Systems of Intellectual Property of Waseda University as a visiting researcher, with the Japan Foundation Fellowship on the research title of "Fansubs and Copyright Protection Levels: A case study into the ANIME Industry of Japan", under the supervision of Prof. Takabayashi Ryu. In Europe, the Ius Commune Research School conferred to him an Honorable Mention in the Ius Commune Prize 2014.

As of 1st August 2016, Dr. He is working as Assistant Professor in School of Law, City University of Hong Kong, in which he is responsible for teaching subjects such as IP law and criminal law. Dr. He is also acting as an External Fellow in IGIR, Maastricht University.

Specialties: Copyright Law, Criminal Law, European Criminal Law, International Trade Law

Lewis Ho leads the life sciences and intellectual property practices in Asia. He helps life sciences and technology companies and their financial sponsors to capture, manage, risk assess, evaluate and monetize their IP assets. His practice focuses on negotiating technology transfer transactions and enforcing IP rights.

Mr. Ho has extensive experience advising on both inbound and outbound IP-driven transactions, and has negotiated more than 60 M&A, collaboration, outsourcing, joint venture and licensing deals. He also assists Chinese companies acquiring IP assets and manufacturing facilities overseas.

Mr. Ho has been consistently recognized by Chambers Asia and Legal 500 as one of the leading life sciences and IP lawyers in China. Chambers Asia noted him for "approaching issues in a 'down-to-earth' manner" and clients described him as "one of the best lawyers I've worked with so far" owing to his sharpness of proactive approach and as producing "a high quality of work." He has also been recognized by IAM Patent 1000 in China.

Prior to joining Loeb & Loeb LLP, Mr. Ho served as a resident partner in the Shanghai and Beijing offices of a major international law firm.

胡晓伟—深圳派富知识产权投资咨询有限公司总经理。毕业于比利时鲁汶天主教大学，曾任中科院深圳先进技术研究院技术转移办公室主任，牛津大学Isis科技创新有限公司驻深圳首席代表， 牛津Isis深圳国际技术转移中心创始人。

2016- Current, General Manager of Shenzhen PAIF Co., Ltd

Due Master degrees KULeuven (Belgium) .

2009-2012, Specialist of international collaboration, Head of technology transfer office, Shenzhen Institutes of Advanced Technologies, China Academy of Sciences

2010-2012, Founder and director of Shenzhen Ritech Robotic Company

2012-2014, Shenzhen Chief representative of Isis Innovation, technology transfer company wholly owned by Oxford University

2014-2016, Founder and CEO of Shenzhen Isis international technology transfer company

Dr. Yuanjia Hu is Associate Professor of Biomedical Sciences and Programme Coordinator of Medicinal Administration in Institute of Chinese Medical Sciences, University of Macau (UM). Dr. Hu is doing multidisciplinary research in medicinal intellectual property. He established patent valuation models specific to drugs, analyzed technology innovation and transfer measured by IP, and published results in SSCI journals in economics and management fields, such as, Technol Anal Strateg Manage, Chin Econ Rev, and Reg Stud. On the other hand, he actively develops new pharmaceutical discovery, especially by employing modern network-based analysis approaches to research Traditional Chinese Medicines. He constructed chemical ingredients network of herbal formulae against CHD and drug-target networks, etc., and published results in SCI journals, such as, PLoS ONE, Expert Opin Ther Pat, eCAM, and Hum Vaccin Immunother. He supervised about 40 Ph.D. and master students and postdoctoral researchers, led and participated in above 10 research projects financed by European Commission, Eurasia Pacific Uninet, Ministry of Science and Technology of China, Development Research Centre of the State Council of China, the National Social Science Fund of China, and the Science and Technology Development Fund of Macao SAR, and further produced over 70 publications including peer-reviewed articles and monographs. He is also IP consultant of Baocheng Law Firm, Project Researcher in the Research Center of National Drug Policy & Ecosystem, Deputy Secretary-General and Executive Council Member in Specialty Committee on Network Pharmacology of World Federation of Chinese Medicine Societies, and Researcher in International Research Center of Medicinal Administration, Peking University. Dr. Yuanjia Hu received B.Sc. degree from China Pharmaceutical University (CPU), UM-CPU dual M.Sc degree in Medicinal administration, Ph.D. degree in Biomedical Sciences from the UM, and Guest Researcher fellowship in Austrian Institute of Technology.

HUANG Hui is a Senior Partner of Wanhuida Peksung, a leading IP service powerhouse formed by the merger of Wan Hui Da Law Firm & IP Agency and PEKSUNG IP Ltd. in November 2016. Dr. HUANG is a multi-faceted intellectual property counsel with stellar academic credentials on China's trademark legislation and practice and a veteran lawyer representing clients in all levels of Chinese courts up to the Supreme People's Court in a wide variety of IP litigations, some of which have become landmark cases.

On account of his expertise in the Trademark Law, Dr. HUANG has been vigorously involved in the initial drafting and subsequent amendments to China's major trademark-related laws, regulations, judicial interpretations, as well as regulatory documents.

Dr. HUANG authors or co-authors a dozen publications, including "Zheng Chengsi IP Anthology – Trademark & Unfair Competition", "Trademark Law", "Legal Protection for Well-known and Famous Marks", "Intellectual Property in European Union", as well as the "Trademark Laws of Twelve Nations". He translates the "Intellectual Property Code of France" (Legislative Part) and has been the executive editor of "China Trademark Report" since 2003.

He was elected Chair of the China Trademark Office Subcommittee of the INTA Trademark Office Practices Committee for the 2014/15 term.

Malavika is the inaugural Executive Director of the Digital Asia Hub, and Faculty Associate at the Berkman Klein Center for Internet & Society at Harvard University. Prior to her relocation to Hong Kong, she spent three years as a Fellow at the Berkman Klein Center, focusing on privacy, identity, biometrics and data ethics. A practising technology lawyer for over 15 years, she spent 8 years in London, with the global law firm Allen & Overy in the Communications, Media & Technology group and as Vice President and Technology Counsel at Citigroup. While a partner at Jayaram & Jayaram in India previously, she was one of 10 Indian lawyers selected for The International Who's Who of Internet e-Commerce & Data Protection Lawyers directory for 2012 and 2013. In 2013, she was voted one of India's leading lawyers – one of only 8 women to be featured in the "40 under 45" survey conducted by Law Business Research, London.

A graduate of the National Law School of India, Malavika has an LL.M. from Northwestern University School of Law, Chicago. She taught India's first ever course on information technology and law in 1997, and as Adjunct Faculty at Northwestern more recently: part of the Master of Science in Law program bridging STEM subjects and the law. She has been a Fellow with the Centre for Internet & Society, India, since 2009 where she helped start their privacy program. She was a Visiting Scholar at the Annenberg School for Communication, University of Pennsylvania, and has had fellowships at the University of Sydney and the Institute for Technology & Society, Rio de Janeiro. She is on the Advisory Board of the Electronic Privacy Information Center (EPIC), and the Executive Committee of the IEEE Global Initiative for Ethical Considerations in Artificial Intelligence and Autonomous Systems.

Mr. Kwok has been working in the semiconductor industry in Silicon Valley since 1979, with extensive trend-setting and start-up (among which being the founding team-member of the last 3 companies) experiences at IDT, Quality Semiconductor Inc., PMC-Flash and NetLogic Microsystems Inc. – 3 IPO's & 1 M&A, covering business developments, then cutting-edge technology developments and applications, IP portfolio developments and licensing, manufacturing operations, as well as product developments and product engineering.

He played a critical role bringing 2 foundation-disruptive technologies mainstream (>90% global market share), laying the foundation for the Information Technology Era: CMOS addressing Hardware platform for Moore's Law scalability at Integrated Device Technology, Inc. as the "Yield Guru" and Network Search Engine/Knowledge Based Processor addressing Network Real-time Interactive "QoS" platform for Metcalfe's Law scalability at NetLogic Microsystems, Inc. as its "Founding Chief IP Officer" and "Product Development Champion".

His "IP" experiences covered in 1989 at Quality Semiconductor Inc. with tech transfers to Japanese strategic partners, then extended to technology licensing to top-tier companies at Programmable Microelectronics Corp. from 1996 to 1998.  The highlight of his IP experiences was being the Founding CIPO at NetLogic Microsystems Inc. (NMI) to conceive and establish the IP portfolio development strategy and blueprint making NMI, though a SME, a dominating IP powerhouse in Silicon Valley (recognized by IEEE in 2006) – IPO in 2004 for ~US$250M & M&A in 2011 by BRCM for US$3.7B. 

He returned to Hong Kong/PRD in 2002 and has been promoting application/modern service platform developments and Innovation/IP management in China. Dr. Kwok was the co-editor of "Handbook of Best Practices In Intellectual Property Management" in Chinese.  He served on the HKSAR IP Working Group from 2013 to 2015.

He has a BSES and a MSEE from the University of Texas at Austin.

Mr. William C.W. Lam holds a Bachelor's Degree of Social Science and a Master's Degree of Business Administration from The Chinese University of Hong Kong. He also holds a Bachelor's Degree of Laws from the University of London. He is now a qualified lawyer in both Hong Kong and England.    Mr. Lam is one of the founders of Hui & Lam Solicitors LLP and he has had experience working in international law firm and multinational company.

Mr. Lam has rich experience in M&A, joint venture, PE funds formation, corporate restructuring and commercial legal services. He has recently handled and successfully completed IPO's for various kinds of companies in Hong Kong and has played leading roles in multi-billion M & A transactions.

Johnson Lam was graduated from the University of Hong Kong and was admitted as a solicitor of the High Court of Hong Kong SAR in 2005.

Johnson specialized in the intellectual property laws. His areas of practice include the registration of trade marks, domain names, designs and patent; trade mark opposition, revocation, restoration and rectification proceedings; handling domain name disputes; enforcement actions relating to anti-counterfeiting and custom actions; assignment and licensing of intellectual property rights etc.

Johnson has also completed a Master of Laws (China Laws) co-hosted by the City University of Hong Kong and the Remin University of China.

Johnson frequently gave talks in relation to IP laws in Hong Kong and China, such as The Law Society of Hong Kong delegation to Chongqing in 2012 and 2013-2015 Asia Adult Expo.

Jyh-An Lee is an Associate Professor of Law at the Chinese University of Hong Kong, where he currently serves as the Deputy Director of the LL.B. Programme and Director of the Centre for Financial Regulation and Economic Development (CFRED) in the Faculty of Law. He holds a J.S.D. from Stanford Law School and an LL.M from Harvard Law School. Dr. Lee has extensively published in English and in Chinese on various aspects of intellectual property and Internet law. His publications appear in leading academic journals, such as Vanderbilt Journal of Entertainment and Technology Law, Cardozo Arts & Entertainment Law Review, Oregon Law Review, Minnesota Journal of Law, Science, and Technology, European Intellectual Property Review (EIPR), Hastings Business Law Journal, American University International Law Review, UMKC Law Review, Jurimetrics, Washington International Law Journal, etc. He is also the single author of two books: Coding a Free Society: Open Source Strategies for Policymakers (VDM Verlag Müller Press, 2007) and Nonprofit Organizations and the Intellectual Commons (Edward Elgar, 2012).

During his studies at Stanford Law School, Dr. Lee was appointed as the John M. Olin Fellow in Law and Economics. Prior to joining the Chinese University of Hong, he taught at National Chengchi University and was an Associate Research Fellow in Center for Information Technology Innovation at Academia Sinica in Taiwan. He was the Legal Lead and Co-Lead of Creative Commons Taiwan (2011-2014) and an advisory committee member for Copyright Amendment in the Taiwan Intellectual Property Office (TIPO) at the Ministry of Economic Affairs (2011-2014). Professor Lee is currently a member of the advisory board of the European Center for E-Commerce & Internet Law affiliated with University of Vienna. He has served as a domain name dispute resolution panelist appointed by the Asian Domain Name Dispute Resolution Centre (ADNDRC) since 2016. Dr. Lee is also the Director of Academic Committee in the Asia Innovation and Intellectual Property Society. Before starting his academic career, he was a practicing lawyer in Taiwan specializing in technology and business transactions.

Alice Lee, Associate Professor and Associate Dean of Faculty of Law, University of Hong Kong, specializes in property law (real property/land law and intellectual property law), legal education and bilingualism. She has contributed to public discussion and consultation on law reforms and published books and book chapters on real property and intellectual property for students, teachers and practitioners. As a panel member of statutory bodies such as the Municipal Services Appeal Board and the Town Planning Appeal Board, she has heard appeals in the relevant areas. She has served on various consultative committees including the Advisory Committee on the Review of the Patent System in Hong Kong. She has also been Co-Legal Lead of Creative Commons HK since its launch in 2008.

Ms. Li Xiaojuan now is the Director of the Intellectual Property Office of Institute of Computing Technology, Chinese Academy of Sciences; meanwhile she is also Assistant Director of the Center of Intellectual Property, Chinese Academy of Sciences. She got her Bachelor Degree of Engineering from Beijing Institute of Technology and Juris Master from Renmin University of China. She is both a patent attorney and a qualified lawyer, with her career mainly focusing on Intellectual Property Rights (IPR) management, patent value analysis, and research achievements commercialization. Over ten years' working experience in these areas offers inspiration for her to publish many papers in different influential journals.

Ms. Li is also public-spirited and has taken a positive part in various social activities. She helped SIPO (State Intellectual Property Office) to issue the national standard "Intellectual property management for research and development organization" (GBT 33250-2016) as an important co-writer. She also played a significant role in the drafting course of AVS (Advanced Audio-Video Coding/Decoding Standard) as co-chairman of the IPR work group. Furthermore, she was elected as judicial assessor of Beijing Intellectual Property Court in 2017. Besides, she has achieved a lot of individual honors as well.

Dr. Waishun Lo is currently General Partner of DL Capitals (點亮資本), an angel investment fund focusing on disruptive and exponential technologies. He is also Adjunct faculty of The Chinese University of Hong Kong (MSc/Entrepreneurship/ IT Management, EMBA/Innovation, OneMBA/Entrepreneurship), and Visiting Professor of PKU (School of Innovation and Entrepreneurship).

His expertise and current interests include Intellectual Property Commercialization, Business Models Innovation and Technology Transfer.

His previous experience includes positions with Bell Labs, Cable & Wireless Innovation, Hong Kong Telecom, and S Venture, an early stage investment company. He had served as Board of Directors for two listed companies in Hong Kong, as panel of assessors of SERAP (Small Entrepreneurs Research Assistance Program), and as Director of the Young Entrepreneurs Development Council.

Dr. Lo was a Senior Researcher at Harvard Business School's (HBS) Asia-Pacific Research Center. He had conducted many consulting projects for institutions and PE funds such as HK Government (regulatory policy), IFC of World Bank (Investment strategy in China), Intellectual Ventures (Invention Network) and had advised many startups in the past.

He holds BSc and Mphil from CUHK, a Ph.D. from Brown University, and has executive management training from INSEAD.

Dr. Hong Lou a Council Member of the Hong Kong Institute of Patent Practitioners Limited. He is a Partner of Sincere Partners & Attorneys in Shenzhen. Specialized in IP law, Dr. Lou holds the degree of Doctor of Juridical Science (JSD) and is a Senior Research Associate in the School of Law, City University of Hong Kong. Before doctorate, he conducted research and study in University College Dublin in Ireland and Emory University in the US. Further, Dr. Lou practices as a Mediator of Shenzhen Nanshan People’s Court, the General Secretory of Belt and Road International Lawyers Union Limited, the Chinese Legal Consultant of Hong Kong General Chamber of Cross-border E-commerce, and the Council Member of Belt and Road International Committee of Shenzhen Lawyers Association. Dr. Lou is the first lawyer qualified as the “Peacock Plan” High-Level Oversea Talent by the Shenzhen Government.

Starting off as an IP litigator, Eugene Low has developed his practice to cover the full spectrum of contentious and advisory IP and TMT work in Hong Kong and China. The experience of seeing how things went wrong enables Eugene to spot risks early, prevent problems from happening and resolve them in a practical manner. 

Serving as an appointed domain name panelist and an accredited mediator also helps Eugene evaluate issues from an adjudicator's perspective. As examples, Eugene has helped clients resolve disputes in all areas of IP including copyright, patents, trademarks and domain names, through litigation, negotiations and alternative dispute resolutions (e.g. arbitration and mediation). 

Eugene also advises and speaks extensively on privacy, data protection, consumer protection and advertising laws – areas which are rapidly-changing in Asia. Again, Eugene covers his clients' full needs, from screening the use of superlatives in online advertisements, to the handling of data/cybersecurity breaches and the defence of investigations by regulators. Given his diverse practice, Eugene has assisted clients from many industry sectors including technology, education, food & beverages, retail, hospitality, financial institutions, sports, gaming and entertainment. 

Eugene features regularly in journals and seminars concerning intellectual property, data privacy, domain names and advertising laws. He is recognised as an outstanding practitioner by various publications including Chambers Asia Pacific, Asialaw Profiles and Asia IP Profiles. 

Eugene speaks English, Mandarin and Cantonese.

US Registered Patent Agent

M.Sc. and Ph.D. (1987) in Biology from the University of Texas at Dallas

B.Sc. in Agricultural Science and Bronze Tablet Scholar from the University of Illinois at Urbana-Champaign

Dr. Jacqueline Lui is a US Patent Agent recognized as one of the World's Leading Patent Individuals by Intellectual Asset Management (IAM). She is also the President of The Hong Kong Institute of Patent Practitioners (HIPP). Dr. Lui has been practicing in the patent field for 20 years, more than 15 of which are in China.  Jackie has experience in the areas of life science, materials science, medical devices, manufacturing, mechanical and chemical engineering. She specializes in cross-jurisdiction patent prosecution, strategic planning, portfolio management, patent due diligence and enforcement.

Working languages: English, Cantonese and Putonghua Chinese

Appointments and Membership:

• President of The Hong Kong Institute of Patent Practitioners Limited (HIPP)
• Member of the Steering Committee on Innovation and Technology of the Government of HKSAR
• Member of the Working Group under the Advisory Committee on Review of the Patent System in Hong Kong, Commerce and Economic Development, the Government of Hong Kong SAR
• Member of the Asian Practice Committee of the Intellectual Property Owners Association (IPO)
• Member of Hong Kong Biotechnology Organization
• Former Member of the Health and Medical Development Advisory Committee (2005 - 2011) of the Government of HKSAR
• Former Member of the Board of Directors of the Applied Science and Technology Research Institute Company Limited (ASTRI) of the Commerce, Industry and Technology Bureau of the Government of HKSAR (2004 - 2010)
• Former Member of the Board of Directors of the R&D Center on Nanotechnology and Advanced Materials (NAMI) (2006 - 2010)

Mr Ng Kim Tean is the Chairman of Nanyang Law LLC, a boutique IP law corporation with 30 staff and 3 offices: 2 offices in Singapore; and 1 office in Kuala Lumpur, Malaysia.

His primary areas of practice are equity capital markets, fund managements, corporate restructurings, commercial and company laws. He also has extensive experience in handling joint ventures, cross- border mergers and acquisitions, take-over, venture capital funding involving American, Chinese and Indonesian laws. With his strong technology background, Mr. Ng provides effective guidance in the field of technology licensing and research collaborations.

His other area of expertise also includes intellectual property law; his many years of hands-on experience have exposed him to all aspects of prosecution and management of intellectual property portfolios including patents, trademarks, registered designs and confidential information in Singapore and various foreign countries.

He is a prolific speaker and he also regularly authors articles, publications and books. His book publications include "International Patent Law – Winning Legal Strategies for Registration, Litigation & Other Intricacies of Patent Law in All Major Markets" (Aspatore, Inc. 2004) and "Intellectual Property for Integrated Circuits" (J Ross Publisher, Inc. 2009).

Mr Ng was a 4-term independent director of a Singapore public-listed company when he successfully re-organized and improved the company's corporate governance after a much-publicized failed take- over saga.

Mr Ng was a 6-term Singapore Representative, Patent Committee of Asian Patent Attorneys Association; he was also a 2-term President of the Singapore Inventors' Development Association; a Part-time Lecturer at Nanyang Technological University; and an Adjunct Faculty of Singapore Management University. He is appointed as a member of the Examination Committee for Patent Agents since 2014. He is also recently conferred as a Fellow of Intellectual Property Technology Consultant Registry.

Mr Ng, an engineer-turned-lawyer, holds a Bachelor of Engineering in Electronics and Electrical Engineering from the National University of Singapore and a Bachelor of Law (Honours) degree from the University of London. He is also qualified as a Barrister-at-law (Middle Temple, London), an Advocate and Solicitor of the Supreme Court of Singapore, and a Singapore Registered Patent Agent.

Jing Ni is an Associate Professor at the East China University of Political Science and Law. After obtaining a postgraduate degree in European Union Law at the Third University of Marseilles, she completed her Ph.D. degree jointly offered by Xiamen University and the same French University, followed by her postdoctoral study at the Chinese Academy of Social Sciences for. Professor Ni is an expert in international protection of intellectual property. She was the principal investigator of a research project "ADR for Intellectual Property Disputes" supported by National Social Science Fund in China and co-investigator in many national or provincial projects. She has published more than 10 articles in prestigious academic journals.

Ms. Carrie Shang is the ADR Legal Counsel of Hong Kong International Arbitration Centre (HKIAC) and she specialized in helping foreign enterprises solving cross-border commercial, investment and intellectual property disputes. Ms. Shang is qualified to practice law in New York and the People's Republic of China. Prior to joining HKIAC, Ms. Shang was an Assistant Professor of Law at the Shanghai University of Finance and Economics (SUFE) and led the University's Free Trade and ADR Research and Development Center, and has provided policy advice to government agencies including the Shanghai Municipal Commission of Commerce. Ms. Shang is fluent in English, Mandarin, and Cantonese, with a good working knowledge of Spanish. She obtained her J.D from the University of Southern California School of Law and her B.A (Honors) from UC Berkeley. Ms. Shang has working and living experiences in the United States, Hong Kong and People's Republic of China, and has also received public interest fellowships from Perkins Coie LLP, the Clinton Global Initiative, and Tata International.

Executive director of Modern Business Development Research Center(focusing on technology commercialization), vice executive president of German Deutsch-Chinesische Allianz für Industrie 4.0 e.V. and chairwoman of Shenzhen Pacific Horizon Investment Management Company Ltd.  Graduated from Nanjing Polytechnic University and EMBA of Chinese University of Hong Kong.  Mrs Wang Dawei used to work in media, fast moving consumer goods, luxury and investment fields, having more than ten years' senior manager's experience on Pepsi and Baoqing Yinlou Chain Store, a famous company in Jiangsu province.  Mrs Wang Dawei used to be in the position of marketing operation executive, operation general manager and general manger.  In recent years, Mrs Wang Dawei focuses on domestic conventional industries' upgrading consultancy, integration of Sino-Foreign technology and bringing in projects that suits Shenzhen's technology industry platform.

Modern Business Development Research Center focuses on technology commercialization.  It promotes integration of Sino-Foreign technology experts, designs commercial paths and provides a series of technology implementation management services in long term.  It is also one of the designated platforms of Shenzhen's Global Innovation Entrepreneurship Express Train.  Now Israel, Germany and Singapore are covered.

Jia Wang is currently an Instructor at Hong Kong Polytechnic University Faculty of Business. Jia teaches in the areas of business law and laws relating to intellectual property and e-commerce. Her research interests cover intellectual property protection and commercialization, online privacy and Internet services providers' liability. Prior to joining PolyU, Jia was a Research Fellow at the Applied Research Centre for Intellectual Assets and the Law in Asia at Singapore Management University and Harvard University Berkman Center for Internet and Society.

Prof. Yitao Wang is Chair Professor and Director of the Institute of Chinese Medical Sciences (ICMS) at the University of Macau (UM), the Director of State Key Laboratory of Quality Research in Chinese Medicine (UM), and Co-Chair & General Secretary of Chinese Joint Research Centre for Drug Discovery and Development (Peking University, National Taiwan University, University of Hong Kong and UM). As the founding Director of the ICMS at the UM and the State Key Laboratory of Quality Research in Chinese Medicine (UM), Prof. Wang is known internationally for his pioneering contributions to the modernisation of Chinese medicine (CM), with an emphasis on systematic evaluation and quality control of CM. He has a long-standing interest in integrating CM research with the cutting-edge areas of systems pharmacology and molecular pharmaceutics. In the past decade, he has published 260 research papers in international peer-reviewed journals included in Science Citation Index (SCI) with a notable h-Index of 36, (co-)edited 16 academic books, and supervised 100+ PhD/MSc graduates and 20 postdoctoral researchers.
Prof. Wang obtained his Bachelor degree (Medical Sciences, 1982) from Chengdu University of Chinese Medicine (CUCM), and completed his postgraduate study (Pharmacology, 1986) at Chongqing Medical University. After working as Visiting Scholar at Hiroshima University in Japan, he returned to CUCM in 1989 where he contributed to mark several firsts in the history of CM – by establishing the first state key subject in CM education, the first Bachelor programme in Pharmacology of CM, the first postdoctoral training programme in CM, as well as the first "National training base for talents in science – CM". He served in turn as Dean and Vice President of CUCM, and moved in 1996 to Beijing to take the post of Vice President and Director of Chinese Academy of Chinese Medical Sciences, where he became in 1999 the Chief Scientist for China's first National Basic Research Program of China (973 Program) in the field of CM. In 2000, Prof Wang was appointed Professor and Director for the CM Programme at the Hong Kong University of Science and Technology (HKUST).

In 2002, Yitao set off for Macau and founded the ICMS at UM, which has in 10 years evolved to be a promising academic hub to provide complete programmes from BSc, MSc, PhD to postdoctoral training in Biomedical Sciences. In 2008, together with other local experts, he drafted the proposal to launch the first state key laboratory in CM. This application was approved in 2010 by the Ministry of Science and Technology of China, which announced to establish in Macao the State Key Laboratory of Quality Research in Chinese Medicine, as China's first state key laboratory in CM. In 2012, he initiated the creation of the Chinese Joint Research Centre for Drug Discovery and Development among Peking University, National Taiwan University, University of Hong Kong and UM, a strategic partnership to mark the first substantial collaboration in science and technology among the four most elite universities in the Greater China region. In line with these accomplishments, Yitao has also initiated joint training programmes and academic collaborations with world-renown universities (e.g. Harvard University, Yale University, University of Chicago and Cambridge University) and organisations (like the World Health Organisation and the US Pharmacopeial Convention).

Prof Wang has been awarded over 30 major funding grants from national, provincial, and special administrative regional administrations. These supports include the prestigious National Basic Research Programme (973), Mega-projects of Scientific Research for 10th Five-Year Plan, China Ministry of Education Key Project, Macao S&T Development Fund, among others. Only in the period between 2010 and 2014, he has been awarded 28 million MOP research funding (20 million of which were obtained externally). His outstanding achievements in academic service have also been recognised by 11 prestigious awards, including the Special Allowance for Experts with Outstanding Contribution from the National Council (1993), National Science and Technology Progress Award (1998), National Intellectual Property Outstanding Achievement Award (1998), Macau Medal of Merit – Education (2011) and 1st Macao Science and Technology Awards - Natural Science Award (2012). In addition, Yitao holds adjunct appointments as Director of International Research Centre of Medicinal Administration at Peking University and as adjunct professors / visiting scholars at numerous universities worldwide, and was elected General Secretory for the International Society for Chinese Medicine and Deputy Secretory for the World Federation of Chinese Medicine Societies. In addition, Yitao serves on several of China's national committee panels including National Science and Technology Programmes, National Basic Research Programme (973), National Natural Science Foundation, the State Science and Technology Awards and National Centre for Drug Evaluation.

Rong Xie is a partner of the Law Offices of Albert Wai-Kit Chan, PLLC.  His practice involves patent and trademark prosecution, patent interference, IP due diligence, licensing, technology transfer, IP-related business transactions and cross-the-border investments.  He also helps clients formulate IP strategies and secure regulatory approvals. Mr. Xie has been working extensively with technology start-up companies in China and the U.S. Over the years, he has represented both industrial and institutional investors and has advised clients in various industries including automotive electronics system, building material, construction, chemistry, healthcare, fashion, software, and energy. 

Mr. Xie has been an active speaker on patent law development and technology transfer between China and the U.S. He has also been actively involved in legal organizations including, among others, United States-China Intellectual Property Institute, Inc. (a New York Not-For-Profit Corporation). Mr. Xie co-taught IP classes at CUNY law school in 2013.

Mr. Xie has a bachelor's degree of law from Shanghai University of International Business and Economics (formerly known as "Shanghai Institute of Foreign Trade") (Shanghai, China), a master's degree of law from Washington University in St. Louis (Missouri, U.S.), and a master degree of science in computer science from Pace University (New York, U.S.).  He is licensed to practice before the United States Patent and Trademark Office, the State of New York, and the United States Court of Appeals for the Federal Circuit.

Ms. Wenxin Yu, Managing Director of Haitong Securities Co., Ltd., chief analyst of pharmaceutical industry, double champion of elections of best sell-side analyst of New Fortune and Crystal Ball in 2015. Best sell-side analyst and frequent first place winner of New Fortune, Crystal Ball, China Business Network, Taurus Award and Thomson Reuters etc. from 2010 to 2015. Senior researcher and critical thinker in segmentation fields of medical service, mobile health, preparation export, blood product, innovative drug and precision medicine. Yu has been invited to give speech in internal conferences of more than 30 listed companies, in more than 10 industrial forums and in companies like Baidu and Alibaba.

As a senior economist and backup-class leading talent credited by Shenzhen government, Dr. Kaijian Yu has deep research in the fields of intellectual property pledge loans, IP investment operation, IP securitization, and international technology transfer. In June 2009, Dr. Yu acquired International Finance PhD degree of Zhejiang University with comprehensive expertise in the fields of material engineering, portfolio investment, and international finance. Dr. Yu had been the researcher of Finance and Market Department of Ningbo Bank in 2009 and had been served for postdoctoral work station of Guosen Securities in 2010. In 2013, Dr. Yu was appointed as the deputy general manager of Strategy Planning Department of Zhuhai Financial Investment Holding Co., Ltd. Since 2015, Dr. Yu has been the vice general manager of Hengqin Intellectual Property Exchange Center Co., Ltd, and taken charge of the Finance Innovation Department and International Business Department.

When Wellsey took over his patent role in Taiwan LED industry, there was a large gulf between Taiwan and Western in terms of their patent strategy concepts. Taiwan domestic academic and research units lacked a "systemic solution," so their impact to the industry were limited. To overcome this problem, Wellsey set up a special work force that adopted novel approaches in patent strategic arts and created a patented patent analysis platform (software + methodology) , compared to the conventional method used by ITRI. Wellsey made his IP team, R&D colleagues, domain experts and industry staffs work closely integrated to channel their resources under his direction of "Dynamic-3D Patent Layout Methodology + Patent Positioning Analysis". Once if the two were combined, the effectiveness of the overall framework would be revealed. Wellsey’s Taiwan customers ended up cross-licenses with foreign giant competitors and won many significant battles in cross boarder patent disputes. This innovative service model was the only successful story in Taiwan and Wellsey was awarded the 1st Taiwan Presidential Innovation Award in 2014.